RXMD:OTC-Progressive Care, Inc (USD)

COMMON STOCK | Pharmaceutical Retailers | OTC

Last Closing Price

USD 0.05

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

0.66M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Progressive Care, Inc., through its subsidiary, Pharmco, LLC, provides prescription pharmaceuticals to individuals and institutions in south Florida. The company operates a retail pharmacy that specializes in the sale of anti-retroviral medications and related patient care management; the sale and rental of durable medical equipment (DME), such as hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories; and the supply of various prescription medications to long term care facilities. It also provides long term care solutions to skilled nursing facilities, assisted living facilities, retirement centers and communities, doctors' offices, and clinics. In addition, the company purchases, repackages, and dispenses prescription and non-prescription pharmaceutical products for its long term care customers. Further, it offers computerized maintenance of patient prescription histories; third party billing; consultant pharmacist services consisting of evaluation of monthly patient drug therapy and monitoring the institution's drug distribution system, as well as home service and maintenance, defective product replacements, and free home installation and instruction services; and data analytics services to support health care organizations. Progressive Care, Inc. was founded in 2005 and is based in Hallandale Beach, Florida.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-06-20 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALBHF Alibaba Health Information Tec..

N/A

USD29.27B 542.50 70.16
RADLY Raia Drogasil S.A

N/A

USD8.89B 84.14 4.34
CLCGY Clicks Group Limited

N/A

USD4.83B 34.98 1.11
ZRSEF Zur Rose Group AG

N/A

USD4.09B N/A N/A
SDGCF Sundrug Co.,Ltd

N/A

USD3.81B 16.60 0.08
FFLWF Fire & Flower Holdings Corp

N/A

USD0.29B N/A 11.91
DRVD Driven Deliveries, Inc

N/A

USD0.06B N/A N/A
HADV Health Advance Inc

N/A

USD0.01B N/A N/A
HEWA HealthWarehouse.com, Inc

N/A

USD8.78M 56.67 N/A
RLLVF Relevium Technologies Inc

N/A

USD2.07M N/A N/A

ETFs Containing RXMD

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Pharmaceutical Retailers)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 52.94% 63% D 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.94% 56% F 71% C-
Trailing 12 Months  
Capital Gain 22.35% 40% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.35% 33% F 36% F
Trailing 5 Years  
Capital Gain 30.07% 50% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.07% 50% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 76.34% 65% D 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.34% 65% D 77% C+
Risk Return Profile  
Volatility (Standard Deviation) 176.37% 41% F 24% F
Risk Adjusted Return 43.29% 71% C- 70% C-
Market Capitalization 0.03B 65% D 40% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Pharmaceutical Retailers)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 23.51 25% F 10% F
EV/EBITDA 17.28 29% F 24% F
Management Effectiveness  
Return on Equity -23.57% 50% F 26% F
Return on Invested Capital -56.02% 13% F 12% F
Return on Assets -10.79% 38% F 31% F
Debt to Equity Ratio -182.01% 100% A+ 97% A+
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.29 65% D 76% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.